...
首页> 外文期刊>Sociedade Brasileira de Medicina Tropical. Revista >Drug-Resistant Mycobacterium tuberculosis Isolates from New and Previously Treated TB Patients in China, 2017-2019
【24h】

Drug-Resistant Mycobacterium tuberculosis Isolates from New and Previously Treated TB Patients in China, 2017-2019

机译:耐药性结核分枝杆菌分离株来自新的和此前治疗的TB患者,2017-2019

获取原文

摘要

Introduction: Mycobacterium tuberculosis (MTB) is a causative agent of tuberculosis (TB) that causes death worldwide. Methods: MTB was subjected to phenotypic drug-susceptibility tests (DST), and drug-resistant genes were sequenced. Results: Previously treated patients were more likely to have positive smear results and exhibit drug resistance. New patients were more likely to be mono SMresistant and less likely to be INH- and RIF-resistant. The most common mutations were katG (S315T), rpoB (S450L), rpsL (K43R), and embB (M306V). Conclusions: The proportion of mono-SM-resistant TB among new patients was higher.
机译:介绍:结核分枝杆菌(MTB)是致癌(TB)的致病因子,导致全世界死亡。 方法:对MTB进行表型药物 - 易感性试验(DST),测序耐药基因。 结果:以前治疗的患者更可能具有阳性涂片结果并表现出耐药性。 新患者更有可能是单声道体积,并且不太可能是无线和防止抗性。 最常见的突变是KATG(S315T),RPOB(S450L),RPSL(K43R)和embB(M306V)。 结论:新患者中单微小TB的比例较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号